Logo image of ZAL.OL

ZALARIS ASA (ZAL.OL) Stock Fundamental Analysis

OSL:ZAL - NO0010708910 - Common Stock

74.6 NOK
-2.3 (-2.99%)
Last: 9/2/2025, 12:47:04 PM
Fundamental Rating

5

ZAL gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 29 industry peers in the Professional Services industry. ZAL has only an average score on both its financial health and profitability. ZAL is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one! These ratings could make ZAL a good candidate for growth investing.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year ZAL was profitable.
ZAL had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: ZAL reported negative net income in multiple years.
Each year in the past 5 years ZAL had a positive operating cash flow.
ZAL.OL Yearly Net Income VS EBIT VS OCF VS FCFZAL.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M -200M

1.2 Ratios

ZAL's Return On Assets of 4.90% is fine compared to the rest of the industry. ZAL outperforms 65.52% of its industry peers.
ZAL has a Return On Equity of 23.85%. This is in the better half of the industry: ZAL outperforms 79.31% of its industry peers.
The Return On Invested Capital of ZAL (12.49%) is better than 75.86% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for ZAL is below the industry average of 10.83%.
The last Return On Invested Capital (12.49%) for ZAL is above the 3 year average (7.14%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 4.9%
ROE 23.85%
ROIC 12.49%
ROA(3y)-0.58%
ROA(5y)-0.28%
ROE(3y)-3.56%
ROE(5y)-2.63%
ROIC(3y)7.14%
ROIC(5y)5.76%
ZAL.OL Yearly ROA, ROE, ROICZAL.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 -20

1.3 Margins

ZAL has a better Profit Margin (3.85%) than 62.07% of its industry peers.
ZAL's Profit Margin has improved in the last couple of years.
ZAL has a better Operating Margin (8.44%) than 68.97% of its industry peers.
ZAL's Operating Margin has improved in the last couple of years.
Industry RankSector Rank
OM 8.44%
PM (TTM) 3.85%
GM N/A
OM growth 3Y38.03%
OM growth 5Y33.39%
PM growth 3Y14.91%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ZAL.OL Yearly Profit, Operating, Gross MarginsZAL.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 -2 4 -4 6 8

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so ZAL is still creating some value.
Compared to 1 year ago, ZAL has about the same amount of shares outstanding.
The number of shares outstanding for ZAL has been increased compared to 5 years ago.
Compared to 1 year ago, ZAL has an improved debt to assets ratio.
ZAL.OL Yearly Shares OutstandingZAL.OL Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
ZAL.OL Yearly Total Debt VS Total AssetsZAL.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

ZAL has an Altman-Z score of 2.98. This is not the best score and indicates that ZAL is in the grey zone with still only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.98, ZAL is in the better half of the industry, outperforming 68.97% of the companies in the same industry.
ZAL has a debt to FCF ratio of 4.34. This is a neutral value as ZAL would need 4.34 years to pay back of all of its debts.
ZAL's Debt to FCF ratio of 4.34 is fine compared to the rest of the industry. ZAL outperforms 62.07% of its industry peers.
ZAL has a Debt/Equity ratio of 1.77. This is a high value indicating a heavy dependency on external financing.
ZAL has a worse Debt to Equity ratio (1.77) than 68.97% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.77
Debt/FCF 4.34
Altman-Z 2.98
ROIC/WACC1.59
WACC7.85%
ZAL.OL Yearly LT Debt VS Equity VS FCFZAL.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M

2.3 Liquidity

A Current Ratio of 1.60 indicates that ZAL should not have too much problems paying its short term obligations.
ZAL has a Current ratio of 1.60. This is amongst the best in the industry. ZAL outperforms 89.66% of its industry peers.
ZAL has a Quick Ratio of 1.60. This is a normal value and indicates that ZAL is financially healthy and should not expect problems in meeting its short term obligations.
ZAL's Quick ratio of 1.60 is amongst the best of the industry. ZAL outperforms 89.66% of its industry peers.
Industry RankSector Rank
Current Ratio 1.6
Quick Ratio 1.6
ZAL.OL Yearly Current Assets VS Current LiabilitesZAL.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

7

3. Growth

3.1 Past

ZAL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 119.98%, which is quite impressive.
Measured over the past years, ZAL shows a very strong growth in Earnings Per Share. The EPS has been growing by 35.55% on average per year.
The Revenue has grown by 44.37% in the past year. This is a very strong growth!
ZAL shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 11.63% yearly.
EPS 1Y (TTM)119.98%
EPS 3Y35.55%
EPS 5YN/A
EPS Q2Q%490.96%
Revenue 1Y (TTM)44.37%
Revenue growth 3Y20.2%
Revenue growth 5Y11.63%
Sales Q2Q%16.21%

3.2 Future

The Earnings Per Share is expected to grow by 15.80% on average over the next years. This is quite good.
ZAL is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 9.20% yearly.
EPS Next Y3.18%
EPS Next 2Y14.82%
EPS Next 3Y15.8%
EPS Next 5YN/A
Revenue Next Year12.75%
Revenue Next 2Y10.52%
Revenue Next 3Y9.2%
Revenue Next 5YN/A

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ZAL.OL Yearly Revenue VS EstimatesZAL.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B
ZAL.OL Yearly EPS VS EstimatesZAL.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 4 6

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 25.64, ZAL can be considered very expensive at the moment.
ZAL's Price/Earnings ratio is in line with the industry average.
ZAL is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 27.13, which is the current average of the S&P500 Index.
ZAL is valuated reasonably with a Price/Forward Earnings ratio of 11.39.
Based on the Price/Forward Earnings ratio, ZAL is valued a bit cheaper than 75.86% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of ZAL to the average of the S&P500 Index (22.76), we can say ZAL is valued slightly cheaper.
Industry RankSector Rank
PE 25.64
Fwd PE 11.39
ZAL.OL Price Earnings VS Forward Price EarningsZAL.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ZAL is valued a bit cheaper than 65.52% of the companies in the same industry.
ZAL's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 13.7
EV/EBITDA 9.6
ZAL.OL Per share dataZAL.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ZAL does not grow enough to justify the current Price/Earnings ratio.
ZAL has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as ZAL's earnings are expected to grow with 15.80% in the coming years.
PEG (NY)8.05
PEG (5Y)N/A
EPS Next 2Y14.82%
EPS Next 3Y15.8%

1

5. Dividend

5.1 Amount

ZAL has a Yearly Dividend Yield of 1.20%. Purely for dividend investing, there may be better candidates out there.
ZAL's Dividend Yield is slightly below the industry average, which is at 3.04.
Compared to an average S&P500 Dividend Yield of 2.32, ZAL's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 1.2%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

DP0%
EPS Next 2Y14.82%
EPS Next 3Y15.8%
ZAL.OL Yearly Income VS Free CF VS DividendZAL.OL Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M -200M

ZALARIS ASA

OSL:ZAL (9/2/2025, 12:47:04 PM)

74.6

-2.3 (-2.99%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)08-29 2025-08-29
Earnings (Next)10-24 2025-10-24
Inst Owners41.95%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.65B
Analysts80
Price Target102 (36.73%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.2%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)2.56%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)4.96%
EPS NY rev (3m)4.96%
Revenue NQ rev (1m)-0.81%
Revenue NQ rev (3m)-0.81%
Revenue NY rev (1m)-0.13%
Revenue NY rev (3m)-0.13%
Valuation
Industry RankSector Rank
PE 25.64
Fwd PE 11.39
P/S 0.96
P/FCF 13.7
P/OCF 11.32
P/B 5.96
P/tB N/A
EV/EBITDA 9.6
EPS(TTM)2.91
EY3.9%
EPS(NY)6.55
Fwd EY8.78%
FCF(TTM)5.44
FCFY7.3%
OCF(TTM)6.59
OCFY8.83%
SpS77.53
BVpS12.52
TBVpS-2.22
PEG (NY)8.05
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 4.9%
ROE 23.85%
ROCE 18.47%
ROIC 12.49%
ROICexc 17.5%
ROICexgc 41.95%
OM 8.44%
PM (TTM) 3.85%
GM N/A
FCFM 7.02%
ROA(3y)-0.58%
ROA(5y)-0.28%
ROE(3y)-3.56%
ROE(5y)-2.63%
ROIC(3y)7.14%
ROIC(5y)5.76%
ROICexc(3y)17.04%
ROICexc(5y)13.22%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)10.55%
ROCE(5y)8.52%
ROICexcg growth 3YN/A
ROICexcg growth 5Y18%
ROICexc growth 3Y28.82%
ROICexc growth 5Y35.65%
OM growth 3Y38.03%
OM growth 5Y33.39%
PM growth 3Y14.91%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score8
Asset Turnover1.27
Health
Industry RankSector Rank
Debt/Equity 1.77
Debt/FCF 4.34
Debt/EBITDA 2.35
Cap/Depr 39.81%
Cap/Sales 1.48%
Interest Coverage 3.49
Cash Conversion 69.95%
Profit Quality 182.39%
Current Ratio 1.6
Quick Ratio 1.6
Altman-Z 2.98
F-Score8
WACC7.85%
ROIC/WACC1.59
Cap/Depr(3y)52.11%
Cap/Depr(5y)45.36%
Cap/Sales(3y)2.71%
Cap/Sales(5y)2.52%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)119.98%
EPS 3Y35.55%
EPS 5YN/A
EPS Q2Q%490.96%
EPS Next Y3.18%
EPS Next 2Y14.82%
EPS Next 3Y15.8%
EPS Next 5YN/A
Revenue 1Y (TTM)44.37%
Revenue growth 3Y20.2%
Revenue growth 5Y11.63%
Sales Q2Q%16.21%
Revenue Next Year12.75%
Revenue Next 2Y10.52%
Revenue Next 3Y9.2%
Revenue Next 5YN/A
EBIT growth 1Y81.66%
EBIT growth 3Y65.91%
EBIT growth 5Y48.9%
EBIT Next Year97.03%
EBIT Next 3Y33.23%
EBIT Next 5YN/A
FCF growth 1Y804.54%
FCF growth 3Y103.15%
FCF growth 5Y43.58%
OCF growth 1Y21161.5%
OCF growth 3Y58.47%
OCF growth 5Y25.33%